Health X Platform Limited Submits FY26 BRSR Report
Health X Platform Limited has submitted its FY25-26 BRSR report, detailing ESG commitments. The report covers corporate identity, operations, and employee data. Paid-up capital is ₹3181.05 Lakhs, with 98.80% turnover from wholesale trading. The company has 2760 employees and focuses on subsidiaries. A penalty of ₹8,00,000 was paid.
The submission of a BRSR report is a standard regulatory compliance for listed companies. It provides information on ESG practices but does not typically have an immediate or significant impact on the company's stock price or business operations unless it reveals exceptionally positive or negative ESG performance or significant risks.
The announcement is a routine filing of the Business Responsibility and Sustainability Report, which is a compliance requirement. While it contains details about the company's operations and commitments, it does not present any new significant positive or negative financial or strategic developments.
Health X Platform Limited (formerly Sastasundar Ventures Limited) has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, in compliance with Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report, which is available on the company's website, details the company's commitment to Environmental, Social, and Governance (ESG) principles.
The BRSR report covers a wide range of disclosures, including corporate identity, business activities, operational locations, employee statistics, and details of its holding and subsidiary companies. It outlines the company's approach to sustainable sourcing, waste management, and employee well-being, including health insurance, maternity benefits, and skill development programs. The report also details the company's commitment to human rights, ethical business practices, and corporate governance.
Key financial and operational highlights from the report indicate a consolidated reporting basis. The company's paid-up capital stands at ₹3181.05 Lakhs. The wholesale trading of pharmaceutical and OTC products constitutes 98.80% of its turnover. The report also highlights that 90% of the company's funds are invested in its subsidiaries, with Sastasundar Healthbuddy Limited being a significant one. The company has a total of 2760 permanent employees, including 183 female employees, and one differently-abled employee. The report also addresses aspects of corporate governance, risk management related to cyber-attacks and competition, and stakeholder engagement. The company has also reported a penalty of ₹8,00,000 for violation of Section 134 of the Companies Act, 2013, which has been paid.
What to do with a filing like this
Health X Platform Limited filed this with the NSE as a statutory disclosure, categorised under business responsibility and sustainability report (brsr). It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Health X Platform Limited. Read the original for the full detail.